Endpoints News’: The New Psychedelic Age in Biotech

Summary: Berra Yazar-Klosinski, Ph.D., joins Endpoints News’ webinar to represent the groundbreaking work of MAPS and MAPS Public Benefit Corporation (MAPS PBC). Consider the benefits, challenges, and controversies of exploring psychedelics through the lens of biotech in the webinar recording

Originally appearing here (Archived)